QOL Medical LLC
Coleen Loer is a seasoned professional in the pharmaceutical industry, currently serving as a Senior Rare Disease Specialist at QOL Medical LLC since December 2022. Previously, Coleen held the position of Territory Consultant at RedHill Biopharma Ltd. for a short tenure in early 2022 and worked at AstraZeneca as a Renal Hospital Specialist from January 2019 to January 2022. Coleen's career with Merck spanned a decade, from 2009 to 2019, where an exemplary performance led to multiple accolades, including the Vice President’s Award in 2014 and 2017, the Director’s Award in 2015 and 2016, and the District MVP Award in 2015 and 2016. Coleen holds a Bachelor's Degree in Communications from UC Santa Barbara.
This person is not in the org chart
This person is not in any offices
QOL Medical LLC
OL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them.QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underservedmarkets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.